Table 2 Surgical and pathological details.
From: Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers
Variables | Total (n = 285) |
|---|---|
Staging operation, n (%) | |
Single-stagea | 192 (67.4) |
Two-stage | 93 (32.6) |
Laterality, n (%) | |
Unilateral | 191 (67.0) |
Bilateral | 94 (33.0) |
Approach, n (%) | |
Unilateral | |
Thoracotomy | 107 (37.5) |
VATS | 84 (29.5) |
Bilateral | |
Thoracotomy+Thoracotomy | 27 (9.5) |
VATS+VATSa | 49 (17.2) |
VATS+Thoracotomy | 18 (6.3) |
Type of surgical resection, n (%) | |
Multi-lobectomy | 87 (30.5) |
Lobectomy+sublobar resectionsb | 139 (48.8) |
Sublobar resections | 59 (20.7) |
Location of lobe, n (%) | |
Same lobe | 55 (19.3) |
Different lobe | 190 (66.7) |
Combined lobec | 40 (14.0) |
No. of tumor, n (%) | |
2 | 234 (82.1) |
3 | 33 (11.6) |
≥4 | 18 (6.3) |
Largest T size, cm, n (%) | |
≤2 | 103 (36.2) |
2 < d ≤ 3 | 93 (32.6) |
3 < d ≤ 5 | 72 (25.3) |
d > 5 | 17 (5.9) |
Histology type, n (%) | |
ADCs (multiple) | 233 (81.8) |
SCCs (multiple) | 27 (9.5) |
ADC+otherd | 9 (3.1) |
SCC+othere | 2 (0.7) |
ADC+SCC | 14 (4.9) |
Subtypes of largest tumorf, n (%) | |
Lepidic predominant | 69 (29.6) |
Acinar predominant | 122 (52.3) |
Papillary predominant | 23 (9.9) |
Micropapillary predominant | 6 (2.6) |
Solid predominant | 13 (5.6) |
Highest pT stageg, n (%) | |
1a | 11 (3.8) |
1b | 45 (15.8) |
1c | 19 (6.7) |
2ah | 175 (61.4) |
2b | 15 (5.3) |
3 | 16 (5.6) |
4 | 4 (1.4) |
pN stage, n (%) | |
0 | 217 (76.1) |
1 | 27 (9.5) |
2 | 41 (14.4) |
Adjuvant chemotherapyi, n (%) | |
Yes | 119 (41.8) |
No | 166 (58.2) |
